Prostacyclin analogs inhibit fibroblast migration

Tadashi Kohyama, Xiang-de Liu, Hui Jung Kim, Tetsu Kobayashi, Ronald F. Ertl, Fu Qiang Wen, Hajime Takizawa, Stephen I. Rennard

Research output: Contribution to journalArticle

27 Citations (Scopus)

Abstract

The controlled accumulation of fibroblasts to sites of inflammation is crucial to effective tissue repair after injury. Either inadequate or excessive accumulation of fibroblasts could result in abnormal tissue function. Prostacyclin (PGI2) is a potent mediator in the coagulation and inflammatory processes. The aim of this study was to investigate the effect of PGI2 on chemotaxis of human fetal lung fibroblasts (HFL-1). Using the blind well chamber technique, we found that the PGI2 analog carbaprostacyclin (10-6 M) inhibited HFL-1 chemotaxis to human plasma fibronectin (20 μg/ml) 58.0 ± 13.2% (P < 0.05) and to platelet-derived growth factor (PDGF)-BB (10 ng/ml) 48.7 ± 4.6% (P < 0.05). Checkerboard analysis demonstrated that carbaprostacyclin inhibits both directed and undirected migration. The inhibitory effect of the carbaprostacyclin was concentration dependent and blocked by the cAMP-dependent protein kinase (PKA) inhibitor KT-5720, suggesting that a cAMP-PKA pathway may be involved in the process. Two other PGI2 analogs, ciprostene and dehydro-15-cyclohexyl carbaprostacyclin (both 10-6 M), significantly inhibited fibroblast migration to fibronectin. In summary, PGI2 appears to inhibit fibroblast chemotaxis to fibronectin and PDGF-BB. Such an effect may contribute to the regulation of fibroblasts in wound healing and could contribute to the pathogenesis of diseases characterized by abnormal tissue repair remodeling.

Original languageEnglish (US)
JournalAmerican Journal of Physiology - Lung Cellular and Molecular Physiology
Volume283
Issue number2 27-2
StatePublished - Aug 3 2002

Fingerprint

Epoprostenol
Fibroblasts
Chemotaxis
Fibronectins
Protein Kinase Inhibitors
Cyclic AMP-Dependent Protein Kinases
Wound Healing
Protein Kinases
Inflammation
Lung
Wounds and Injuries
carboprostacyclin

Keywords

  • Inflammation
  • Prostaglandin I
  • Protein kinase
  • Tissue repair

ASJC Scopus subject areas

  • Physiology
  • Pulmonary and Respiratory Medicine
  • Physiology (medical)
  • Cell Biology

Cite this

Kohyama, T., Liu, X., Kim, H. J., Kobayashi, T., Ertl, R. F., Wen, F. Q., ... Rennard, S. I. (2002). Prostacyclin analogs inhibit fibroblast migration. American Journal of Physiology - Lung Cellular and Molecular Physiology, 283(2 27-2).

Prostacyclin analogs inhibit fibroblast migration. / Kohyama, Tadashi; Liu, Xiang-de; Kim, Hui Jung; Kobayashi, Tetsu; Ertl, Ronald F.; Wen, Fu Qiang; Takizawa, Hajime; Rennard, Stephen I.

In: American Journal of Physiology - Lung Cellular and Molecular Physiology, Vol. 283, No. 2 27-2, 03.08.2002.

Research output: Contribution to journalArticle

Kohyama, T, Liu, X, Kim, HJ, Kobayashi, T, Ertl, RF, Wen, FQ, Takizawa, H & Rennard, SI 2002, 'Prostacyclin analogs inhibit fibroblast migration', American Journal of Physiology - Lung Cellular and Molecular Physiology, vol. 283, no. 2 27-2.
Kohyama, Tadashi ; Liu, Xiang-de ; Kim, Hui Jung ; Kobayashi, Tetsu ; Ertl, Ronald F. ; Wen, Fu Qiang ; Takizawa, Hajime ; Rennard, Stephen I. / Prostacyclin analogs inhibit fibroblast migration. In: American Journal of Physiology - Lung Cellular and Molecular Physiology. 2002 ; Vol. 283, No. 2 27-2.
@article{08ebd517b2ac4771bf4da82e06cc3915,
title = "Prostacyclin analogs inhibit fibroblast migration",
abstract = "The controlled accumulation of fibroblasts to sites of inflammation is crucial to effective tissue repair after injury. Either inadequate or excessive accumulation of fibroblasts could result in abnormal tissue function. Prostacyclin (PGI2) is a potent mediator in the coagulation and inflammatory processes. The aim of this study was to investigate the effect of PGI2 on chemotaxis of human fetal lung fibroblasts (HFL-1). Using the blind well chamber technique, we found that the PGI2 analog carbaprostacyclin (10-6 M) inhibited HFL-1 chemotaxis to human plasma fibronectin (20 μg/ml) 58.0 ± 13.2{\%} (P < 0.05) and to platelet-derived growth factor (PDGF)-BB (10 ng/ml) 48.7 ± 4.6{\%} (P < 0.05). Checkerboard analysis demonstrated that carbaprostacyclin inhibits both directed and undirected migration. The inhibitory effect of the carbaprostacyclin was concentration dependent and blocked by the cAMP-dependent protein kinase (PKA) inhibitor KT-5720, suggesting that a cAMP-PKA pathway may be involved in the process. Two other PGI2 analogs, ciprostene and dehydro-15-cyclohexyl carbaprostacyclin (both 10-6 M), significantly inhibited fibroblast migration to fibronectin. In summary, PGI2 appears to inhibit fibroblast chemotaxis to fibronectin and PDGF-BB. Such an effect may contribute to the regulation of fibroblasts in wound healing and could contribute to the pathogenesis of diseases characterized by abnormal tissue repair remodeling.",
keywords = "Inflammation, Prostaglandin I, Protein kinase, Tissue repair",
author = "Tadashi Kohyama and Xiang-de Liu and Kim, {Hui Jung} and Tetsu Kobayashi and Ertl, {Ronald F.} and Wen, {Fu Qiang} and Hajime Takizawa and Rennard, {Stephen I.}",
year = "2002",
month = "8",
day = "3",
language = "English (US)",
volume = "283",
journal = "American Journal of Physiology - Renal Physiology",
issn = "0363-6127",
publisher = "American Physiological Society",
number = "2 27-2",

}

TY - JOUR

T1 - Prostacyclin analogs inhibit fibroblast migration

AU - Kohyama, Tadashi

AU - Liu, Xiang-de

AU - Kim, Hui Jung

AU - Kobayashi, Tetsu

AU - Ertl, Ronald F.

AU - Wen, Fu Qiang

AU - Takizawa, Hajime

AU - Rennard, Stephen I.

PY - 2002/8/3

Y1 - 2002/8/3

N2 - The controlled accumulation of fibroblasts to sites of inflammation is crucial to effective tissue repair after injury. Either inadequate or excessive accumulation of fibroblasts could result in abnormal tissue function. Prostacyclin (PGI2) is a potent mediator in the coagulation and inflammatory processes. The aim of this study was to investigate the effect of PGI2 on chemotaxis of human fetal lung fibroblasts (HFL-1). Using the blind well chamber technique, we found that the PGI2 analog carbaprostacyclin (10-6 M) inhibited HFL-1 chemotaxis to human plasma fibronectin (20 μg/ml) 58.0 ± 13.2% (P < 0.05) and to platelet-derived growth factor (PDGF)-BB (10 ng/ml) 48.7 ± 4.6% (P < 0.05). Checkerboard analysis demonstrated that carbaprostacyclin inhibits both directed and undirected migration. The inhibitory effect of the carbaprostacyclin was concentration dependent and blocked by the cAMP-dependent protein kinase (PKA) inhibitor KT-5720, suggesting that a cAMP-PKA pathway may be involved in the process. Two other PGI2 analogs, ciprostene and dehydro-15-cyclohexyl carbaprostacyclin (both 10-6 M), significantly inhibited fibroblast migration to fibronectin. In summary, PGI2 appears to inhibit fibroblast chemotaxis to fibronectin and PDGF-BB. Such an effect may contribute to the regulation of fibroblasts in wound healing and could contribute to the pathogenesis of diseases characterized by abnormal tissue repair remodeling.

AB - The controlled accumulation of fibroblasts to sites of inflammation is crucial to effective tissue repair after injury. Either inadequate or excessive accumulation of fibroblasts could result in abnormal tissue function. Prostacyclin (PGI2) is a potent mediator in the coagulation and inflammatory processes. The aim of this study was to investigate the effect of PGI2 on chemotaxis of human fetal lung fibroblasts (HFL-1). Using the blind well chamber technique, we found that the PGI2 analog carbaprostacyclin (10-6 M) inhibited HFL-1 chemotaxis to human plasma fibronectin (20 μg/ml) 58.0 ± 13.2% (P < 0.05) and to platelet-derived growth factor (PDGF)-BB (10 ng/ml) 48.7 ± 4.6% (P < 0.05). Checkerboard analysis demonstrated that carbaprostacyclin inhibits both directed and undirected migration. The inhibitory effect of the carbaprostacyclin was concentration dependent and blocked by the cAMP-dependent protein kinase (PKA) inhibitor KT-5720, suggesting that a cAMP-PKA pathway may be involved in the process. Two other PGI2 analogs, ciprostene and dehydro-15-cyclohexyl carbaprostacyclin (both 10-6 M), significantly inhibited fibroblast migration to fibronectin. In summary, PGI2 appears to inhibit fibroblast chemotaxis to fibronectin and PDGF-BB. Such an effect may contribute to the regulation of fibroblasts in wound healing and could contribute to the pathogenesis of diseases characterized by abnormal tissue repair remodeling.

KW - Inflammation

KW - Prostaglandin I

KW - Protein kinase

KW - Tissue repair

UR - http://www.scopus.com/inward/record.url?scp=0036076614&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036076614&partnerID=8YFLogxK

M3 - Article

VL - 283

JO - American Journal of Physiology - Renal Physiology

JF - American Journal of Physiology - Renal Physiology

SN - 0363-6127

IS - 2 27-2

ER -